Twelve patients diagnosed with MSA carried an FGF14 GAA250–299 expansion, half of whom (6/12) had a pathologically confirmed diagnosis (Supplementary Table 3 and the Supplementary material, ‘Data’ sections). The gene discussed is FGF14; the disease is multiple system atrophy.